logo
Plus   Neg
Share
Email

West Pharmaceutical Services To Replace Helmerich & Payne In S&P 500

S&P Dow Jones Indices said that S&P MidCap 400 constituent West Pharmaceutical Services Inc. (WST) will replace Helmerich & Payne Inc. (HP) in the S&P 500.

Helmerich & Payne will replace J.C. Penney Company Inc. (JCP) in the S&P SmallCap 600, and Physicians Realty Trust (DOC) will replace West Pharmaceutical Services in the S&P MidCap 400.

S&P Dow Jones Indices stated that J.C. Penney filed to reorganize under Chapter 11 of the U.S. Bankruptcy Code and is no longer eligible for continued inclusion in the S&P SmallCap 600.

Helmerich & Payne has a market capitalization that is more representative of the small-cap market space.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients. Ferring Pharmaceuticals US is recalling various nasal sprays citing superpotency or amounts of desmopressin higher than specified, the U.S. Food and Drug Administration announced in a statement. The recall involves all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL. U.S. President Donald Trump has issued executive orders to ban Chinese mobile application TikTok as well as WeChat, citing a threat to national security and its economy. China's ByteDance Ltd. owns TikTok, a video-sharing mobile app, while Tencent Holdings Ltd. owns WeChat, a messaging, social media, and electronic payment app.
RELATED NEWS
Follow RTT